The right dose for you: Managing treatment & quality of life | Innovations in breast cancer care

You may not need the highest dose to get the best results. Sarah Sammons, MD and patient advocate Janice Cowden joined us for a session on how dosing decisions are made, why some people may benefit from dose adjustments, and how to talk to your team about reducing side effects while keeping treatment effective. About the speakers Sarah Sammons, MD Sarah Sammons, MD, is an associate clinician at Dana-Farber Cancer Institute in Boston, Massachusetts, and a faculty member of Harvard Medical School. Her clinical work specializes in the treatment of all stages of breast cancer. Janice Cowden Janice Cowden is a dedicated research patient advocate and serves as the patient advocate research lead in the American Society of Clinical Oncology CDK Dosing Study, representing the Patient-Centered Dosing Initiative (PCDI). This is the second session of our four-part series, "Effective treatment & side effect support | Innovations in breast cancer care". When you’re facing breast cancer, understanding your options can make all the difference. This series brings together leading experts and patient advocates to help you speak up for your needs, manage side effects, and navigate treatment decisions with confidence. This free, four-part webinar series is designed to help people with breast cancer — whether facing a new diagnosis, in treatment, or living with metastatic disease — get real answers to real challenges. Learn more about the series here: https://www.lbbc.org/community/events/innovations-in-care-2025 At Living Beyond Breast Cancer, we make sure people facing breast cancer have the support they need. We’re here with real answers, real stories, and real help—every step of the way. Follow us: Facebook: https://www.facebook.com/livingbeyondbreastcancer LinkedIn: https://www.linkedin.com/company/living-beyond-breast-cancer Instagram: https://instagram.com/livingbeyondbc YouTube: https://youtube.com/user/LBBC1991